Literature DB >> 34375606

Tumor heterogeneity.

Dana Pe'er, Seishi Ogawa, Ofer Elhanani, Leeat Keren, Trudy G Oliver, David Wedge.   

Abstract

Tumor heterogeneity was traditionally considered in the genetic terms, but it has now been broadened into many more facets. These facets represent a challenge in our understanding of cancer etiology but also provide opportunity for us to understand prognosis and therapy response.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2021        PMID： 34375606     DOI： 10.1016/j.ccell.2021.07.009

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  5 in total

1.  New classification for advanced breast cancer patients experiencing disease progression during salvage treatment: a single-center retrospective cohort study.

Authors:  Jiahuai Wen; Liping Ren; Wenxia Li; Junhong Li; Lezhen Huang; Zhongyu Yuan; Qianjun Chen
Journal:  Ann Transl Med       Date:  2022-05

2.  Preoperative platelet distribution width-to-platelet ratio combined with serum thyroglobulin may be objective and popularizable indicators in predicting papillary thyroid carcinoma.

Authors:  Jin Jin; Guihua Wu; Chengwei Ruan; Hongwei Ling; Xueman Zheng; Changjiang Ying; Ying Zhang
Journal:  J Clin Lab Anal       Date:  2022-04-20       Impact factor: 3.124

Review 3.  Odontogenic MSC Heterogeneity: Challenges and Opportunities for Regenerative Medicine.

Authors:  Yuan Chen; Zhaoyichun Zhang; Xiaoxue Yang; Anqi Liu; Shiyu Liu; Jianying Feng; Kun Xuan
Journal:  Front Physiol       Date:  2022-04-19       Impact factor: 4.755

Review 4.  Recent Progress in Bio-Responsive Drug Delivery Systems for Tumor Therapy.

Authors:  Xiufeng Cong; Jun Chen; Ran Xu
Journal:  Front Bioeng Biotechnol       Date:  2022-06-29

5.  A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma.

Authors:  Jiahao Gao; Fangdie Ye; Fang Han; Haowen Jiang; Jiawen Zhang
Journal:  Front Immunol       Date:  2022-09-13       Impact factor: 8.786
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.